IMMIX BIOPHARMA, INC.
1140 West Olympic Blvd., Suite 200
Los Angeles, CA 90064
December 13, 2021
VIA EDGAR
United States Securities and Exchange Commission
100 F. Street, NE
Washington, DC 20549
| Attention: | Gary Newberry |
| Al Pavot | |
| Jane Park | |
| Laura Crotty |
| Re: | Immix Biopharma, Inc. | |
| Registration Statement on Form S-1, as amended | ||
| File No. 333-259591 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Immix Biopharma, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:45 p.m.., Eastern Standard Time, on Wednesday, December 15, 2021, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| Thank you, | ||
| IMMIX BIOPHARMA, INC. | ||
| By: | /s/ Ilya Rachman | |
| Name: | Ilya Rachman | |
| Title: | Chief Executive Officer | |